Quantification of CD34+ cells: Comparison of methods

Transfusion

Volumn 37, Issue 8, 1997, Pages 775-784

  Fritsch, G ^a   Printz, D ^a,b   Stimpfl, M ^a,b   Dworzak, M N ^a,b   Witt, V ^a,b   Potschger U ^a,b   Buchinger, P ^a,b  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b Children's Cancer Research Institute

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL LOSS; CONTROLLED STUDY; CYTOLYSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKAPHERESIS; LYMPHOCYTE COUNT;

EID: 0030773977     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37897424398.x     Document Type: Article

References (32)

1. Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992;1:329-41.
2. Bensinger W, Singer J, Appelbaum F, et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993;81:3158-63.
3. Dreger P, Marquardt P, Haferlach T, et al. Effective mobilisation of peripheral blood progenitor cells with "Dexa-BEAM" and G-CSF: timing of harvesting and composition of the leukapheresis product. Br J Cancer 1993;68:950-7.
4. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993;21:508-14.
5. Pettengell R, Morgenstern GR, Woll PJ, et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993;82:3770-7.
6. Bolwell BJ, Goormastic M, Yanssens T, et al. Comparison of G-CSF and GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 1994;14:913-8.
7. Brugger W, Henschler R, Heimfeld S, et al. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994;84:1421-6.
8. Rosenfeld CS, Gremba C, Shadduck RK, et al. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation. Exp Hematol 1994;22:290-4.
9. Shpall EJ, Jones RB, Bearman SI, et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994;12:28-36.
10. Negrin RS, Kusnierz-Glaz CR, Still BJ, et al. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood 1995;85:3334-41.
11. Tricot G, Jagannath S, Vesole D, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995;85:588-96.
12. Zimmerman TM, Lee WJ, Bender JG, et al. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant 1995;15:439-44.
13. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-9.
14. Wunder E, Sovalat H, Fritsch G, et al. Report on the European Workshop on Peripheral Blood Stem Cell Determination and Standardization - Mulhouse, France, February 6-8 and 14-15, 1992. J Hematother 1992;1:131-42.
15. Sovalat H, Wunder E, Tienhaara A, et al. Commentary: prospects for standardization of stem cell determination within Europe. J Hematother 1993;2:293-6.
16. Johnsen HE. Report from a Nordic workshop on CD34+ cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories. J Hematother 1995;4:21-8.
17. Siena S, Bregni M, Di Nicola M, et al. Milan protocol for CD34+ cell estimation in peripheral blood for autografting in patients with cancer. In: Wunder E, Sovalat H, Henon PR, Serke S, eds. Hematopoietic stem cells; the Mulhouse Manual. Dayton, OH: AlphaMed Press, 1994:23-30.
18. Cassens U, Fischer J, Fritsch G, et al. Durchflußzytometrische Analyse CD34 exprimierender hämatopoetischer Zellen in Blut und Zytaphereseprodukten. Infusionsther Transfusionsmed 1996;23(Suppl 2):1-23.
19. Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996;5:213-26.
20. Brecher ME, Sims L, Schmitz J, et al. North American Multicenter Study on flow cytometric enumeration of CD34+ hematopoietic stem cells. J Hematother 1996;5:227-36.
21. Johnsen HE, Knudsen LM. Nordic flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: report from the second Nordic Workshop. Nordic Stem Cell Laboratory Group (NSCL-G) J Hematother 1996;5:237-45.
22. Sutherland DR, Keating A, Nayar R, et al. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994;22:1003-10.
23. Fritsch G, Stimpfl M, Kurz M, et al. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Bone Marrow Transplant 1996;17:169-78.
24. Tiirikainen MI. Evaluation of red blood cell lysing solutions for the detection of intracellular antigens by flow cytometry. Cytometry 1995;20:341-8.
25. Kreissig C, Kirsch A, Serke S. Characterization and measurement of CD34-expressing hematopoietic cells. J Hematother 1994;3:263-89.
26. McCarthy DA, Macey MG, Cahill MR, Newland AC. Effect of fixation on quantification of the expression of leucocyte function-associated surface antigens. Cytometry 1994;17:39-49.
27. Payne TA, Traycoff CM, Laver J, et al. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation. Bone Marrow Transplant 1995;15:187-92.
28. Kotylo PK, Sample RB, Redmond NL, Hibner GC. Reference ranges for lymphocyte subsets. A comparison of standard vs rapid whole-blood lysis techniques. Arch Pathol Lab Med 1991;115:181-4.
29. Serke S, Huhn D. Improved specificity of determination of immature erythrocytes (reticulocytes) by multiparameter flow-cytometry and thiazole orange using combined staining with monoclonal antibody (anti-glycophorin-A). Clin Lab Haematol 1993;15:33-44.
30. Fritsch G, Buchinger P, Printz D, Gadner H. Relative enrichment of hematopoietic progenitor cells: efficiency of a repeated density centrifugation. J Lab Clin Med 1991;118:359-62.
31. Lumley MA, McDonald DF, Czarnecka HM, et al. Quality assurance of CD34+ cell estimation in leucapheresis products. Bone Marrow Transplant 1996;18:791-6.
32. Ho AD, Young D, Maruyama M, et al. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both. Exp Hematol 1996;24:1460-8.